Timing of carbon nanoparticles injection for thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This trial tests whether the timing of a carbon nanoparticle injection during thyroid cancer surgery improves outcomes. It may help patients who need their whole thyroid removed and have cancer in both lobes or spread to lymph nodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your thyroid cancer is less than 4 cm wide
- You have cancer in both sides of your thyroid, or it has spread to neck lymph nodes
- Your vocal cords are working normally (checked a week before surgery)
- You have not had thyroid surgery before, and you need to have your whole thyroid removed
- Your blood pressure is under control, and you are able to talk and understand after surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a targeted medication (mitoxantrone hydrochloride) during robotic thyroid surgery helps treat thyroid cancer more effectively, while also aiming to reduce side effects. The goal is to improve surgical outcomes and quality of life for patients with early-stage thyroid cancer.
This study looks at whether certain cancer “targeted therapy” medicines can make radioactive iodine (RAI) therapy work better for thyroid cancer that has spread to the lungs. It also involves taking special whole-body scans to measure how much radioactive iodine gets taken up by the cancer.
This trial tests a combination of two drugs, sinibolimab (an immunotherapy) and lenvatinib (a targeted therapy), given before surgery to shrink locally advanced thyroid cancer that cannot be fully removed. The goal is to make the tumor removable and improve outcomes.
This trial is for people with low-risk papillary thyroid cancer. It compares two surgical approaches: one that removes just the thyroid gland, and another that also removes some lymph nodes in the center of the neck as a preventive measure. The goal is to see if removing these lymph nodes helps prevent the cancer from coming back.
This trial is testing whether thyroid hormone replacement after surgery is safe for people with low-risk papillary thyroid cancer. It may help maintain normal hormone levels after part of the thyroid is removed.
This trial tests a new way to choose chemotherapy for thyroid cancer by growing a 'mini-tumor' (organoid) from your biopsy and testing different drugs on it. The goal is to find the drug that is most likely to shrink your cancer.
Hear when a new Papillary Thyroid Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.